Previous 10 | Next 10 |
Preannounces Preliminary Third Quarter 2023 Results OptimizeRx adds new, proven, profitable technologies to become the most comprehensive healthcare marketing platform in the nation. Consolidated revenue run rate will increase to nearly $100 million and the acquisition is expect...
WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced a n...
WALTHAM, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the expansion of its AI-enabled healthcare technology platf...
2023-08-21 06:45:00 ET Summary After making a new 2023 high on July 31, the market is now in the process of consolidating its gains and expanding its participation. The best performer last week was Volatility, as investors looked for ways to protect their gains from further downsi...
2023-08-15 13:14:27 ET Gainers: Delcath Systems ( DCTH ) +96% . Sacks Parente Golf ( SPGC ) +95% . Novo Integrated Sciences ( NVOS ) +61% . T2 Biosystems ( TTOO ) +45% . Siyata Mobile ( SYTA ) +36% . Grove Collaborative Holdi...
2023-08-15 10:17:36 ET Gainers: Delcath Systems ( DCTH ) +90% . Pharvaris ( PHVS ) +22% . ENDRA Life Sciences ( NDRA ) +14% . NeurAxis ( NRXS ) +12% . SomaLogic ( SLGC ) +12% . Losers: Design Therapeutics ( DSGN ) -6...
2023-08-14 18:54:08 ET OptimizeRx Corporation. (OPRX) Q2 2023 Earnings Conference Call August 14, 2023, 04:30 PM ET Company Participants William Febbo - Chief Executive Officer Edward Stelmakh - Chief Financial and Operating Officer Stephen Silvestro - Chief Comm...
2023-08-14 16:02:21 ET More on OptimizeRx OptimizeRx Aims For Growth After Swoon OptimizeRx Q4 top line miss, lackluster 2023 revenue guidance drives shares down 19% Hilton Grand Vacations rallies after S&P MidCap 400 Index callup OptimizeRx stock sinks 2...
– RWD.AI-enabled portion of the core business sees 186% YOY growth during the first half of 2023 – Non-core business is lagging – Total revenue of $13.8 million – GAAP net loss per share of $(0.24) – Non-GAAP net loss per sh...
2023-08-13 17:35:24 ET Major earnings expected after the bell on Monday include: Suncor Energy ( SU ) Canoo ( GOEV ) Sachem Capital Corp. ( SACH ) Astra Space ( ASTR ) Ayro ( AYRO ) For further details see: Notable earnings after Monday's ...
News, Short Squeeze, Breakout and More Instantly...
OptimizeRx Corporation Company Name:
OPRX Stock Symbol:
NASDAQ Market:
OptimizeRx Corporation Website:
WALTHAM, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a confere...
WALTHAM, Mass., July 23, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced its conti...
WALTHAM, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the resul...